Department of Medicine 5 – Haematology and Oncology

Impact of IDH1 and IDH2 mutational subgroups in acute myeloid leukemia patients after allogeneic hematopoietic cell transplantation (2022) Kunadt D, Stasik S, Metzeler K, Roellig C, Kramer M, Greif P, Spiekermann K, et al. Conference contribution Role of CAR T Cell Metabolism for Therapeutic Efficacy (2022) Rial Saborido J, Völkl S, Aigner M, Mackensen A, Mougiakakos D Journal article, Review article Which factors determine our medical actions? Responsible medicine in the age of tight economic constraints (2022) Combs SE, Krause S, Moesta T, Schmidberger H Journal article, Editorial Feasibility, Safety, and Preliminary Efficacy of Very Low-Volume Interval Training in Advanced Cancer Patients (2022) Reljic D, Herrmann HJ, Jakobs B, Dieterich W, Mougiakakos D, Neurath M, Zopf Y Journal article Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages (2022) Zeller T, Lutz S, Münnich IA, Windisch R, Hilger P, Herold T, Tahiri N, et al. Journal article Methodological Establishment of an in-vitro ADCC Assay by using patient-specific Immune Cells (2022) Lehle S, Völkl S, Rübner M, Emons J, Seitz K, Beckmann M, Fasching P, Hübner H Conference contribution, Conference Contribution Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium (2022) Lüke F, Haller F, Utpatel K, Krebs M, Meidenbauer N, Scheiter A, Spörl S, et al. Journal article Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation (2022) Kunadt D, Stasik S, Metzeler KH, Roellig C, Schliemann C, Greif PA, Spiekermann K, et al. Journal article Dual immune checkpoint blockade of LILRB1 and CD47 enhances antibody-dependent cellular phagocytosis of lymphoma cells by CD20 antibodies (2022) Zeller T, Lutz S, Muennich IA, Windisch R, Hilger P, Herold T, Tahiri N, et al. Conference contribution Dysregulation of the B lymphocyte compartment in patients with chronic graft-versus-host disease (2022) Habenicht KM, Bootz A, Schneider A, Schäfer S, Hoffmann P, Winkler J, Wolff D, Winkler T Conference contribution